创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: Humanized Model of the Immune System

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-01-23 16:44
  • Views:

(Summary description)The Humanized Model of the Immune System (HMIS) from InnoModels Biotechnology is a leading research technology designed to provide advanced and reliable tools for biomedical research, help scientists better understand the complex mechanisms of the human immune system, and advance scientific progress in the fields of immunotherapy, infectious diseases, and therapeutic treatments for illnesses.

InnoModels Biotechnology: Humanized Model of the Immune System

(Summary description)The Humanized Model of the Immune System (HMIS) from InnoModels Biotechnology is a leading research technology designed to provide advanced and reliable tools for biomedical research, help scientists better understand the complex mechanisms of the human immune system, and advance scientific progress in the fields of immunotherapy, infectious diseases, and therapeutic treatments for illnesses.

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-01-23 16:44
  • Views:
Information

The Humanized Model of the Immune System (HMIS) from InnoModels Biotechnology is a leading research technology designed to provide advanced and reliable tools for biomedical research, help scientists better understand the complex mechanisms of the human immune system, and advance scientific progress in the fields of immunotherapy, infectious diseases, and therapeutic treatments for illnesses.
1. Simulating the human immune system: The humanized model of the immune system constructs a unique model that mimics the human immune system by integrating multiple cell types, such as T-cells, B-cells, and NK-cells, as well as associated cytokines and signaling pathways. This enables researchers to more realistically simulate human immune responses in the laboratory.
2. Multi-field research applications: The model is widely used in immunotherapy, cancer research, infectious diseases, autoimmune diseases and other research fields. Researchers can use this model for drug screening, disease modeling, immune response mechanism research, etc. 3.

 


3. Advantage of humanization: The unique feature of the humanized model of the immune system is its humanized nature, which enables researchers to better study the specificity and complexity of the human immune system. This helps to more accurately assess the effectiveness of potential treatments and drugs.
4. Customized Services: InnoModels Biotechnology offers customized services to researchers by providing different types and configurations of humanized models of the immune system according to their research needs. This flexibility helps to meet the individual needs of different research projects.
5. Highly controllable experimental conditions: The model provides highly controllable conditions in experiments, allowing researchers to adjust cell composition, concentration, and other parameters to simulate a variety of physiological and pathological states, thus allowing for more in-depth study of the multifaceted functions of the immune system.
By providing advanced humanized models of the immune system, InnoModels Biotechnology provides strong support to researchers and promotes scientific exploration and innovation in the field of immunology. The application of such models will help deepen the understanding of immune system diseases and therapeutic approaches, and provide a scientific basis for the development and clinical application of new therapeutic strategies.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司